Fredun Pharmaceuticals standalone net profit rises 8.38% in the September 2024 quarter

Net profit of Fredun Pharmaceuticals rose 8.38% to Rs 4.27 crore in the quarter ended September 2024 as against Rs 3.94 crore during the previous quarter ended September 2023. Sales rose 31.19% to Rs 106.89 crore in the quarter ended September 2024 as against Rs 81.48 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	106.89	81.48	31
OPM %	13.04	11.79	-
PBDT	8.63	6.71	29
PBT	7.57	5.77	31
NP	4.27	3.94	8